Back to Search Start Over

Vasorelaxant effects of 1-nitro-2-phenylethene in rat isolated aortic rings.

Authors :
Arruda-Barbosa L
Rodrigues KM
Souza-Neto Fd
Duarte GP
Borges RS
Magalhães PJ
Lahlou S
Source :
Vascular pharmacology [Vascul Pharmacol] 2014 Nov; Vol. 63 (2), pp. 55-62. Date of Electronic Publication: 2014 Aug 15.
Publication Year :
2014

Abstract

Previously, we showed that nitro-2-phenylethane is a vasorelaxant constituent of the essential oil of Aniba canelilla. Here, we investigated the mechanisms underlying the vascular effects of 1-nitro-2-phenylethene (NPe), a structural analog of 1-nitro-2-phenylethane obtained synthetically, in rat isolated thoracic aortic preparations. At 0.1-100 μg/mL, NPe similarly relaxed endothelium-intact or endothelium-denuded aortic preparations pre-contracted with 60mM KCl or with phenylephrine (PHE, 1 μM). Vasorelaxant effects of NPe against PHE-induced contractions remained unaffected following blockade of potassium channels by TEA, and inhibition of either nitric oxide synthase by l-NAME, cyclooxygenase by indomethacin or guanylate cyclase by ODQ. In preparations maintained under Ca(2+)-free conditions, NPe significantly reduced the contractions induced (i) by PHE, but not those evoked by caffeine, (ii) by CaCl2 in either PHE (in the presence of 1 μM verapamil)- or KCl-stimulated preparations, (iii) by extracellular Ca(2+) restoration in thapsigargin-treated aortic preparations, and (iv) by the activator of protein kinase C phorbol-12,13-dibutyrate or the inhibitor of protein tyrosine phosphatase sodium orthovanadate. It is concluded that NPe induced an endothelium-independent vasorelaxation with potency greater than its structural analog 1-nitro-2-phenylethane. Such action appears to occur intracellularly probably through inhibition of contractile events that are clearly independent of Ca(2+) influx from the extracellular milieu.<br /> (Copyright © 2014 Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1879-3649
Volume :
63
Issue :
2
Database :
MEDLINE
Journal :
Vascular pharmacology
Publication Type :
Academic Journal
Accession number :
25131395
Full Text :
https://doi.org/10.1016/j.vph.2014.08.002